Terumo Corp (4543) - Product Pipeline Analysis, 2020 Update

Terumo Corp (4543) - Product Pipeline Analysis, 2020 Update

  • July 2020 •
  • 93 pages •
  • Report ID: 5072488 •
  • Format: PDF
Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment.Its major product categories include pharmaceuticals, blood bags, disposable medical devices, nutritional food supplement, cardiovascular systems, vascular grafts, blood glucose monitoring system, peritoneal dialysis, medical electronic, and digital thermometers.

The company’s systems find applications in and interventional therapies performed inside blood vessels and cardiac and vascular surgery.Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients.

The company operates through subsidiaries and associate companies in Japan, China, Europe, North America, South America, Asia Pacific, the Middle East and Africa. Terumo is headquartered in Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Terumo Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.